Targeting the Bundibugyo Strain with Obeldesivir The World Health Organization (WHO) has launched the EBO-PEP clinical trial, the first to test the antiviral drug obeldesivir as a post-exposure treatment for …
Tag:
vaccines
-
-
GSK Canada Careers: Strategic Leadership in Vaccine Commercial Operations GSK, a global biopharmaceutical company, maintains a significant operational footprint in Mississauga, Ontario, where it manages complex commercial mandates for its …
-
Older adults who received the recombinant zoster vaccine (Shingrix) after being admitted to a skilled nursing facility showed a 24% lower risk of receiving a new dementia diagnosis over a …
-
Instead, roughly three in ten adults occupy a "mixed middle"—a group characterized by uncertainty and inconsistent beliefs—which public health experts identify as a critical demographic for targeted, accurate communication. Understanding …
-
A Nominee’s Skepticism of Vaccine Science Sean Kaufman, the Trump administration’s nominee for Assistant Secretary for Preparedness and Response at the Department of Health and Human Services (HHS), has a …
-
Genetic engineering technologies capable of modifying human traits exist today, and their integration with artificial intelligence is accelerating the potential for human enhancement. While these tools offer prospects for medical …
-
Single-Shot Vaccine Under Development Could Protect Against Flu, COVID-19, and RSV A single-shot vaccine targeting influenza, COVID-19, and respiratory syncytial virus (RSV) is being developed by researchers, aiming to address …
-
The European External Action Service: Navigating Institutional Tensions in EU Foreign Policy The European External Action Service (EEAS) currently faces significant internal friction as member states—notably France and Germany—clash with …
-
Common vaccine myths, including debunked claims about autism and COVID-19 vaccine safety, continue to circulate among the U.S. public, contributing to a "malleable middle" of uncertainty that influences childhood vaccination …
-
Public Trust in AI Declines as Skepticism Outpaces Adoption Public concern over artificial intelligence in the U.S. has outpaced adoption, with 52% of Americans more concerned than excited about AI …
Newer Posts